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I IJI Ul II If we are going to live so intimately with these chemicals-eating and
drinking them, taking them into the very marrow of our bones-we
had better know something about their nature and their power.
Rachel Carson, SilentSpring, 1962
Functional Food Fights
One of the mostly hotly debated questions
in nutrition today is whether-and how
well-so-called functional foods are being
regulated. Conventional foods become mar-
ketable as functional foods when they are
supplemented with ingredients that confer
health benefits beyond basic nutrition-
souped-up soup, one might say. On 25
March 1999, the Center for Science in the
Public Interest (CSPI), a nonprofit health
advocacy group in Washington, DC,
released a report titled Functional Foods:
Public Health Boon or 21st Century
Quackery? The report describes the func-
tional foods markets in the United States,
Japan, and the United Kingdom, and issues
a strong call to the U.S. Food and Drug
Administration (FDA) to more
tightly regulate the labeling and mar-
keting ofthese products.
Functional foods hold tremen-
dous promise for benefiting public
health. Problems arise, says the
report, when functional foods claim
that a particular ingredient confers
some health benefit when there may
be no conclusive evidence support-
ing the claim. Some functional food
products may contain insignificant
amounts ofthe promoted ingredient
as well as unhealthful ingredients,
such as fat and sugar, that override
any health benefit provided by the
functional ingredient.
A key problem, contends the Fordup
report, is that the distinction
between foods and drugs is becoming
increasingly blurred as the number offunc-
tional foods on the market continues to
grow. Some functional foods are being mar-
keted as dietary supplements, says Ilene
Ringel Heller, a senior staff attorney for the
CSPI and a coauthor of the report, when
they should be regulated as foods with
unapproved additives or as drugs. Dietary
supplements are defined under the 1994
Dietary Supplement Health and Education
Act (DSHEA, pronounced "de SHAY") as
edible substances with ingredients such as
vitamins, minerals, herbs, and amino acids
that are taken to augment the nutrients
derived from conventional foods. Prior to
1994, the FDA could regulate dietary sup-
plements as food additives, which must
have FDA approval prior to marketing
unless they are considered to be generally
recognized as safe. DSHEA prohibited the
FDA from treating dietary supplements as
food additives; although the FDA still
requires a 75-day notification period prior
to the marketing of a new dietary supple-
ment (during which time the agency may
challenge any labeling claims made by the
manufacturer), FDAapproval is not actually
required for a dietary supplement to be put
on the market.
DSHEA also allows the use of struc-
ture/function claims on supplement labels.
These statements can be difficult to distin-
guish from health claims-claims that a
product will prevent, cure, or treat a dis-
ease-which must be specifically approved
by the FDA. For example, the
structure/function claim "Calcium is neces-
sary for bone growth and development"
becomes a health claim if the word "osteo-
for thought. Grocery manufacturers, the FDA, and public
s are embroiled in a debate overthe labeling offunctional foo
porosis" is introduced into the statement.
The CSPI report claims that some man-
ufacturers seek to avoid costly and time-
consuming FDA approval entanglements
by taking advantage ofwhat it classifies as
DSHEA's less stringent provisions; indeed,
says Heller, some manufacturers are mar-
keting functional foods as dietary supple-
ments and making structure/function
claims that are essentially implied health
claims. For instance, says the report, the
labels on Hain Kitchen Prescription canned
soups, which contain medicinal herbs such
as echinacea, indicate the products are sup-
plements and feature structure/function
claims normally found on dietary supple-
ment labels. But Stacey Zawel, vice presi-
dent of scientific and regulatory policy at
Grocery Manufacturers of America, an
industry organization based in Washington,
DC, says this is an inaccurate leap on the
report's part. She says, "Provisions for func-
tional foods and dietary supplements are
simply different-not necessarily less or
more stringent. If you really dissect the
laws, you will find that it's a wash as to
which is more difficult.... The law already
requires all products to present labeling
information that is truthful and not mis-
leading. There is no difference for any
claim you make on your food,
structure/function or otherwise."
Furthermore, Zawel says, there is absolutely
no evidence ofan onslaught ofinappropri-
ate structure/function claims. She says,
"Every example that is provided in [the
CSPI report] is perfectly legal under FDA
law." Heller calls this stance "disingenu-
ous, saying, "The examples . . . speak for
themselves."
The report makes several rec-
ommendations for FDA action.
First, the FDA should prohibit
companies from marketing func-
tional foods as dietary supple-
ments, and make it clear that
health claims for functional foods
are subject to the same preap-
proval requirements that apply to
all other foods. Functional ingre-
t dients added to foods should be
L regulated as food additives unless
i they are generally recognized as
safe, and the FDA should also
impose tighter regulation ofstruc-
ture/function claims for foods and
interest require that they be based on uni-
ids. versally recognized scientific facts, such as the fact that calcium is
necessary for bone growth and develop-
ment. The report also recommends that the
FDA establish a postmarket surveillance sys-
tem that would monitor adverse health
effects from functional ingredients in foods.
Finally, the report recommends that the
FDA require foods making structure/func-
tion claims to meet certain nutritional
guidelines: they must not contain unhealth-
ful levels offat, saturated fat, cholesterol, or
sodium, and they should, prior to fortifica-
tion, contain at least 10% of the recom-
mended daily intake of certain desirable
nutrients such as vitamin C.
For now, the two sides ofthe functional
foods debate remain at loggerheads. Zawel
says, [Functional foods] are governed by all
laws covering conventional foods. It is that
simple. The FDA has conveyed to us that,
in fact, no new regulations are needed to
regulate these products." Heller maintains,
however, that "the FDA has to begin
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addressing the regulation of functional
foods. 'Functional foods' is a concept that
everyone knows aboutbutforwhich there is
no official policy. The FDA must face the
issues raised bythese products to ensure that
functional foods become a public health
boon rather than the snake oil of the 21st
century.
Estrogen's a Natural in Herbal
Remedies
Patricia Eagon, an associate professor of
medicine at Pennsylvania's University of
Pittsburgh, decided to consult an herbalist
after she began to suspect that Premarin, the
prescription estrogen she was taking for
menopausal symptoms, was causing a rash
on her leg. The herbalist, whom she had
consulted before on other health matters,
gave her a mixture of several herbs to take
instead of Premarin. The concoction both
relieved Eagon's hot flashes and
piqued her curiosity about how the
herbal ingredientsworked.
Eagon decided to launch her own
experiment to find out. She conduct-
ed an estrogen-binding assay on 15
herbs commonly used in treating
menopause, including 3 from the
remedy she had taken herself. Herbs
that showed estrogenic activity in the
screening were then fed to rats that
had undergone ovariectomy. To test
the herbs' estrogenicity, Eagon
weighed the rats' uteri at the end of
the study and measured changes in
the concentration ofluteinizing hor-
mone in their blood (enlarged uterus
and decreased luteinizing hormone
concentration are both indicators of
estrogenic activity). The tests indicated an
estrogenic effect in four of the herbs-
chaste tree berry (Vitex agnus-castus), dong
quai (Angelica sinensis), American ginseng
(Panax quinquefolium), and black cohosh
(Cimicifuga racemosa). Eagon reported her
findings on 11 April 1999 at the annual
meeting of the American Association for
Cancer Research and is currently preparing
the results for publication.
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Herbal estrogens. A recent study by associate professor of medicine
Patricia Eagon suggests that some herbs may have powerful estrogenic
properties.
Eagon's findings have implications for
the fast-growing number ofpeople who are
embracing alternative medicine. According
to the U.S. Food and Drug Administration
(FDA), more than halfofall U.S. adults use
over-the-counter vitamins, dietary supple-
ments, or herbal remedies. Ann Fonfa,
founder ofthe New York City-based Annie
Appleseed Project to promote the study of
alternative cancer treatments, estimates
(based on national averages for the general
population) that 30% of menopausal
women treat themselves with medicinal
herbs, many because they believe such herbs
are safer and gentler than prescription
drugs. Yet they have no proofofthe herbs'
medicinal value and safety beyond the folk
wisdom ofherbalists; unlike pharmaceutical
manufacturers, manufacturers of herbal
remedies are not required by the FDA to
prove their products' safetyand efficacy.
Eagon's discovery ofestrogenicity in the
herbs she tested comes as no surprise to
some researchers. "While the specific find-
ings are new, there is well-known, well-
described estrogenic activity in plants," says
Daniel Sheehan, director of the Endocrine
Disruptor Knowledge Base Program of the
FDA's National Center for Toxicology
Research in Jefferson, Arkansas. He points
to the example ofsubterranean clover, a type
of clover that farmers have known for 50
years to cause reproductive failure in sheep.
While Eagon's research may help
explain why certain herbs may relieve hot
flashes and other menopausal symptoms, it
raises several more questions. Ofkey inter-
est is how these phytoestrogens react in the
body. "We really need to measure these
things inwomen," Eagon says.
Premarin has long been doctors' drug of
choice in treating menopause because it not
only relieves symptoms but also helps pre-
vent osteoporosis and heart disease.
However, the synthetic hormone also ele-
vates women's risk of breast and uterine
cancer, which scares many would-be users
away.
Because of the estrogenic activity she
observed in the herbs she studied, Eagon
feels compelled to warn women at high risk
of breast or uterine cancer against taking
them, as estrogen has been implicated in
some forms of cancer. Yet she admits she
doesn't know if the herbs promote cancer.
In fact, she says, "We may test these further
and find they inhibit cancer. It looks as if
soy has a positive effect in preventing breast
cancer. These herbs may also be able to pre-
vent it."
Eagon also doesn't know if estrogenic
herbs give women the same protection
against heart disease and osteoporosis that
synthetic estrogen does. "One question is,
how do estrogenic substances from plants
compare in activity with pharmaceutical
estrogens," says Fredi Kronenberg, director
ofthe Rosenthal Center for Complementary
and Alternative Medicine at Columbia
University College of Physicians and
Surgeons in New York City. "Do they have
a broadspectrum ofestrogenic activityor are
they more selective in action? We don't have
theansweryet.`
Some ofthose answers may come out of
Eagon's upcoming research. She first plans
to investigate whether the herbs inhibit or
promote breast cancer by feeding them to
rats with a genetic susceptibility to the dis-
ease. Eagon also plans to delve into the
herbs' effects on premenopausal
women. Younger women take
chaste tree berry and dong quai
for premenstrual syndrome,
amenorrhea, and infertility;
American ginseng is recommend-
ed for stomach upset, lack of
appetite, physical exhaustion,
and infection. Eagon would use
mice with intact ovaries to simu-
late the impact on pre-
menopausal women.
"People think [taking herbal
remedies] is like eating another
serving of broccoli," Eagon says.
"These things are not all benign.
The more we know about them,
the better offwe'll be."
Harvesting Monoclonal
Antibodies from Plants
When monoclonal antibodies were first
developed 20 years ago, they were hyped as
a magic bullet for curing cancer and other
diseases. However, killing cancer cells with
these immune proteins, which are artificially
produced and which neutralize one specific
antigen or foreign protein, was not as
straightforward as first assumed, and clinical
failures occurred. Moreover, the high costof
producing monoclonal antibodies by tradi-
tional cell fermentation methods limited
their applications. These setbacks have
forced scientists to look more realistically at
monoclonal antibodies.
Now, researchers at EPIcyte Pharma-
ceutical, based in San Diego, California,
hope to revitalize interest in monoclonal
antibodies with a new technology that pro-
duces large supplies ofthe proteins inexpen-
sively. Their new technology uses green
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